NDPSC record of reasons, 41st meeting, 22-23 June 2004
National Drugs and Poisons Schedule Committee
The Record of the Reasons contains the basis of scheduling decisions and other outcomes arising from the meeting. Please note that the Record of the Reasons includes extracts from the NDPSC minutes which have been edited to remove confidential information.
*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
NDPSC Record of reasons Meeting 41 (pdf,544kb)
Contents
Glossary
- 1.5 Administration
- 1.5.1 Correction to the Minutes of the NDPSC 38th Meeting - Melaleuca Oil
- 1.5.2 Correction to the Minutes of the NDPSC 39th (October 2003) & 40th (February 2004) Meetings - Hyoscyamus niger
- 1.8 Trans-Tasman Harmonisation Working Party
- 1.8.1 Minutes from the 10th (October 2003) TTHWP Meeting
- 1.8.1.1 Phenylephrine
- 1.8.1.4 Propantheline
- 1.8.2 Matters arising from previous consideration of TTHWP items
- 1.8.2.1 Meclozine
- 1.8.2.2 Amphotericin
- 1.8.2.3 Definition for "Day-Night" preparations
- 1.8.2.4 Injectable preparations
- 1.8.1 Minutes from the 10th (October 2003) TTHWP Meeting
Agricultural/Veterinary, Industrial and Domestic Chemicals
3. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)
- 3.1 10,10'-oxydiphenoxarsine (OBPA)
- 3.2 Child-resistant packaging definition
4. Other outstanding matters from previous meetings
- 4.1 Eyelash and eyebrown tinting products
- 4.2 Methylcyclopentadienyl manganese tricarbonyl
- 4.3 Creosote
- 4.4 Alkaline salts
- 4.5 Vinclozolin
5. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
- 5.1 SUSDP, Part 4
- 5.2 SUSDP, Part 5
- 5.2.1 Bifluorides
6. Matters referred by the Australian Pesticides and Veterinary Medicines Authority
- 6.1 Molinate
- 6.2 Gonadotrophin releasing hormone
- 6.3 Potassium bicarbonate
- 6.4 Octenol
- 6.5 Firocoxib
- 6.6 Quinclorac
- 6.7 Flumiclorac pentyl ester
- 6.8 Permethrin
7. Matters referred by Office of Chemical Safety (OCS)
- 7.1 Androstenedione albumen conjugate with DEA dextran adjuvant
8. Antibiotics for consideration following recommendations of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR)
- 8.1-8.7 Sulfonamides
- 8.8 Tiamulin
9. Other matters for consideration
- 9.1 Sodium hypochlorite
- 9.2 Sodium fluoroacetate
10. Initial review and/or formal opinions (ag/vet, industrial & domestic chemicals)
11. Information items (ag/vet, industrial & domestic chemicals)
Pharmaceuticals
12. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)
- 12.1 Triamcinolone
- 12.2 Sodium fluoride
- 12.3 Mitragyna speciosa
13. Other outstanding matters from previous meetings
- 13.1 Melia azedarach
- 13.2 Pancreatic enzymes
- 13.3 Pseudoephedrine
- 13.4 Medical devices
- 13.5 Kava and kavalactones
- 13.6 Aripiprazole
- 13.7-13.9 [Items deleted]
- 13.10 Ibuprofen
14. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons
- 14.1 SUSDP, Part 4
- 14.1.1 Diclofenac
- 14.1.2 Nicotine
- 14.2 SUSDP, Part 5
15. Matters referred by the Australian Drug Evaluation Committee (ADEC)
- 15.1 New substances
- 15.1.1 Atomoxetine
- 15.1.2 Atazanavir
- 15.1.3 Treprostinil
- 15.1.4 Amotosalen
- 15.1.5 Ciclesonide
- 15.1.6 Rosuvastatin
- 15.1.7 Alefacept
- 15.1.8 Aprepitant